AXIOS (Adriel Bettelheim) - AI giants lean into health care to stall public backlash
AI has an image problem . And one way to fix it is for top companies to dive headlong into health care. Why it matters: Saving the world with AI-designed cures is better than being blamed for ruining the environment or driving up Americans' utility bills. - But even the most advanced AI models can't produce miracle treatments at the moment — and could create serious security risks if they try. - That could set up a fraught debate over the next two or three years about the allocation of resources and whether the benefits of throwing vast amounts of computing capacity into medical research outweigh the costs. Driving the news: The Wall Street Journal reported this month that Anthropic was trying to shore up investor confidence ahead…
What are some of the primary concerns the U.S. public has regarding the expansion of AI data centers?
The public has expressed "NIMBY" (Not In My Backyard) sentiments, including the implementation of moratoriums, threatened lawsuits, and fears that AI models might take over jobs.
Q&A ID 25d7ad7e-8976-41b6-b386-a34b37f07942
Why are frontier AI labs like Anthropic and OpenAI preparing to go public?
These companies are preparing to go public to help cover the massive costs associated with maintaining multi-gigawatt computing infrastructures and training new models.
Q&A ID ef6038db-1e3c-4495-8c92-fea46d126c14
What specific measures did Anthropic take regarding its Claude Fable 5 model?
Anthropic implemented strict safeguards on its next-generation Claude Fable 5 model after determining the model could provide "significant uplift" to a bad actor.
Q&A ID bf65ef7b-2851-4c4a-95ea-95394cc05a3e
Which pharmaceutical companies is Isomorphic Labs currently collaborating with for research?
Isomorphic Labs has ongoing research collaborations with Novartis, Eli Lilly, and Johnson & Johnson.
Q&A ID 0c106193-5295-43ca-bdb4-9fa7cc492f56
How much capital did Isomorphic Labs, a spinoff from Google focused on AI drug discovery, recently raise?
Isomorphic Labs recently raised $2.1 billion to fund the hiring of additional clinical and AI talent.
Q&A ID dc159a1d-98d7-4e4e-be83-22c45e8adfd2
What major companies are collaborating to build a $1 billion drug discovery lab in San Francisco?
Nvidia and Eli Lilly are building a $1 billion drug discovery lab in San Francisco intended to bring together life science researchers with engineers and AI model builders.
Q&A ID cf10828c-ae66-4156-a61b-fd001113e66b
